Bioaccessibility, biotransformation, and transport of α-mangostin from Garcinia mangostana (Mangosteen) using simulated digestion and Caco-2 human intestinal cells

Molecular Nutrition and Food Research

Volumn 53, Issue SUPPL. 1, 2009, Pages

  Bumrungpert, Akkarach ^a   Kalpravidh, Ruchaneekorn W ^b   Suksamrarn, Sunit ^c   Chaivisuthangkura, Apinya ^c   Chitchumroonchokchai, Chureeporn ^d   Failla, Mark L ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c SRINAKHARINWIROT UNIVERSITY   (Thailand)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Bioaccessibility; Caco 2 human intestinal cells; In vitro digestion; Mangosteen; Xanthones

Indexed keywords

MANGOSTIN; XANTHONE DERIVATIVE;

ARTICLE; BIOAVAILABILITY; CELL STRAIN CACO 2; CHEMISTRY; DIGESTION; DRUG STABILITY; FRUIT; GARCINIA MANGOSTANA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; METABOLISM; MICELLE; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIGESTION; DRUG STABILITY; FRUIT; GARCINIA MANGOSTANA; HUMANS; MICELLES; XANTHONES;

GARCINIA MANGOSTANA;

EID: 66749135984     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800260     Document Type: Article

References (40)

1. Moongkarndi, P., Kosem, N., Kaslungka, S., Luanratana, O. et al., Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line, J. Ethnopharmacol. 2004, 90, 161-166.
2. Jung, H. A., Su, B. N., Keller, W., Mehta, R. G., Kinghorn, A. D., Antioxidant xanthones from pericap of Garcnia mangostana (Mangosteen), J. Agric. Food Chem. 2006, 54, 2077-2082.
3. Mahabusarakam, W., Wiriyachitra, P., Taylor, W. C., Chemical constitutes of Garcinia mangostana, J. Nat. Prod. 1987, 50,474-478.
4. Balunas, M. J., Su, B., Brueggemeier, R. W., Kinghorn, D. A., Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity, J. Nat. Prod. 2008, 71, 1161-1166.
5. Chairungsrilerd, N., Takeuchi, K., Ohizumi, Y., Nozoe, S., Ohta, T., Mangostanol, a prenyl xanthone from Garcinia mangostana, Phytochemistry 1996, 43, 1099-1102.
6. Suksamrarn, S., Suwannapoch, N., Phakhodee, W., Thanuhiranlert, J. et al., Antimycobacterial activity of prenylated xanthones from the fruits of Garcinia mangostana, Chem. Pharm. Bull. 2003, 51, 857-859.
7. Vlietinck, A. J., De Bruyne, T., Apers, S., Pieters, L. A., Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection, Planta Med. 1998, 64, 97-109.
8. Riscoe, M., Kelly, J. X., Winter, R., Xanthones as antimalarial agent: Discovery, mode of action and optimization, Curr. Med. Chem. 2005, 12, 2539-2549.
9. Matsumoto, K., Akao, Y., Kobayashi, E., Ohguchi, K., et al., Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines, J. Nat. Prod. 2003, 66, 1124-1127.
10. Matsumoto, K., Akao, Y., Ohguchi, K., Ito, T., et al., Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells, Bioorg. Med. Chem. 2005, 13, 6064-6069.
11. Williams, P., Ongsakul, M., Proudfoot, J., Croft, K., Beilin, L., Mangostin inhibits the oxidative modification of human low density lipoprotein, Free Radic. Res. 1995, 23, 175-184.
12. Nakatani, K., Nakahata, N., Arakawa, T., Yasuda, H., Ohizumi, Y., Inhibition of cyclooxygenase and prostaglandin E2 synthesis by γ-mangostin, a xanthone derivative in mangosteen, in C6 rat glioma cells, Biochem. Pharmarcol. 2002, 63, 73-79.
13. Nakatani, K., Yamakuni, T., Kondo, N., Arakawa, T., et al., γ-Mangostin inhibits inhibitor-ΚB kinase activity and decreases lipopolysaccharide-induced cyclooxygenase-2 gene expression in C6 rat glioma cells, Mol. Pharmacol. 2004, 66, 667-674.
14. Chen, L. G., Yang, L. L., Wang, C. C., Anti-inflammatory activity of mangostins from Garcinia mangostana, Food Chem. Toxicol. 2008, 46, 688-693.
15. Weecharangsan, W., Opanasopit, P., Sukma, M., Ngawhirunpat, T. et al., Antioxidative and neuroprotective activities of extracts from the fruit hull of Mangosteen (Garcinia mangostana Linn.), Med. Princ. Pract. 2006, 15, 281-287.
16. Leontowicz, M., Leontowicz, H., Drzewiecki, J., Jastrzebski, Z., et al., Two exotic fruits positively affect rat's plasma composition, Food Chem. 2007, 102, 192-200.
17. Sampath, P. D., Vijayaraghavan, K., Cardioprotective effect of α-mangostin, a xanthone derivative from mangosteen, on tissue defense system against isoproterenol-induced myocardial infarction in rats, J. Biochem. Mol. Toxicol. 2007, 21, 336-339.
18. Suksumrarn, S., Komutiban, O., Ratananukul, P., Chimnoi, N., et al., Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana, Chem. Pharm. Bull. 2006, 54, 301-305.
19. Garrett, D. A., Failla, M. L., Sarama, R. J., Development of an in vitro digestion method to assess carotenoid bioavailability from meals, J. Agric. Food Chem. 1999, 47, 4301-4309.
20. Malagelada, J. R., Longstreth, G. F., Summerskill, W. H. J., Go, V. L. W., Measurement of gastric functions during digestion of ordinary solid meals in man, Gastroenterology 1976, 70,203-210.
21. Chitchumroonchokchai, C., Schwartz, S. J., Failla, M. L., Assessment of lutein bioavailability from meals and a supplement using simulated digestion and Caco-2 human intestinal cells, J. Nutr. 2004, 134, 2280-2286.
22. Failla, M. L., Huo, T., Thakkar, S. K., Invitro screening of relative bioaccessibility of carotenoids from foods, Asian Pac. J. Clin. Nutr. 2008, 17 (S1), 200-203.
23. Pinto, M., Robine-Leon, S., Appay, M., Kedenger, M., et al., Enterocyte-like differentiation and polarization the human colon carcinoma cell line Caco-2 in culture, Biol. Cell. 1983, 47,323-330.
24. Mehran, M., Levy, E., Bendayan, M., Seidman, E., Lipid, apolipoprotein, and lipoprotein synthesis and secretion during cellular differentiation in Caco-2 cells, In Vitro Cell. Dev. Biol. 1997, 33, 118-128.
25. Luchoomun, J., Hussain, M. M., Assembly and secretion of chylomicrons by differentiatied Caco-2 cells, J. Biol. Chem. 1999,274,19565-19572.
26. Delie, F., Rubas, W., A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: Advantages and limitations of Caco-2 model, Cri. Rev. Therap. Drug Carr. Sys. 1997, 14, 221-286.
27. Meunier, V., Bourrie, M., Berger, Y., Fabre, G., The human intestinal epithelial cell line Caco-2: pharmacological and pharmacokinetic applications, Cell Biol. Toxicol. 1995, 11, 187-194.
28. Sun, D., Lennernas, H., Welage, L. S., Barnett, J. L., et al., Comparison of human duodenum and Caco-2 gene expression profiles for 12 000 gene sequences tags and correlation with permeability of 26 drugs, Pharm. Res. 2002, 19, 1400-1416.
29. Englund, G, Rorsman, F., Ronnblom, A., Karlbom, U., et al., Regional levels of drug transporters along the human intestinal tract: Co-expression of ABC and SLC transporters and comparison with Caco-2 cells, Eur. J. Pharm. Sci. 2006, 29, 269-277.
30. Murota, K., Shimizu, S., Miyamoto, S., Izumi, T., et al., Unique uptake and transport of isoflavone aglycones by human intestinal Caco-2 cells: Comaprison of isoflavonoids and flavonoids, J. Nutr. 2002, 132, 1956-1961.
31. Galijatovic, A., Otake, Y., Walle, U. K., Walle, T., Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells, Xenobiotica 1999, 29, 1241-1256.
32. Steensma, A., Noteborn, H. P. J. M., Kuiper, H. A., Comparison of Caco-2, IEC-18 and HCEC cell lines as a model for intestinal absorption of genistein, daidzein and their glycosides, Environ. Toxicol. Pharmacol. 2004, 16, 131-139.
33. Zhang, L., Chow, M. S., Zuo, Z., Efect of the co-occurring components from green tea on the intestinal absorption and disposition of green tea polyphenols in Caco-2 monolayer model, J. Pharm. Pharmacol. 2006, 58, 37-44.
34. Usta, M., Wortelboer, H. M., Vervoort, J., Boersma, M. G., et al., Human glutathione S-transferase-mediates glutathione conjugation of curcumin and efflux of these conjugates in Caco-2 cells, Chem. Res. Toxicol. 2007, 20, 1895-1902.
35. Simons, A. L., Renouf, M., Henrich, S., Murphy, P. A., Human gut microbial degradation of flavonoids: Structure-function relationships, J. Agric. Food Chem. 2005, 72, 40-45.
36. Ou, B., Ji, H., Kou, Y., Kondo, M., Bioavailability and antioxidant effects of a xanthone-rich dietary supplement in humans, Experimental Biology 2008, San Diego, CA. April 5-9,2008.Abstract LB803.
37. Anwar, K., Iqbal, J., Hussain, M. M., Mechanisms involved in vitamin E transport by primary enterocytes and in vivo absorption, J. Lipid Res. 2007, 48, 2028-2038.
38. Nayak, N., Harrison, E. H., Hussain, M. M., Retinyl ester secretion by intestinal cells: A specific and regulated process dependent on assembly and secretion of chylomicrons, J. Lipid Res. 2001, 42, 272-280.
39. Brown, M. J., Ferruzzi, M. G., Nguyen, M. L., Cooper, D. A., et al., Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection, Am. J. Clin. Nutr. 2004,80,396-403.
40. Wen, X., Walle, T., Methylated flavonoids have greatly improved intestinal absorption and metabolic stability, Drug Metab. Dispos. 2006, 34, 1786-1792.